Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions

Area of Science:

• Neuroscience
• Biomedical Engineering
• Cell Biology

Background:

• Hypothermia is the standard treatment for global cerebral ischemia (GCI) post-cardiac arrest but has adverse effects.
• Photobiomodulation (PBM) therapy, using low-level laser light, is a noninvasive approach for brain injury.
• Investigating PBM as a novel therapeutic strategy for GCI is warranted.

Purpose of the Study:

• To evaluate the neuroprotective and functional recovery effects of PBM therapy initiated after GCI.
• To elucidate the underlying mechanisms of PBM's therapeutic action on neuronal and mitochondrial health.
• To identify key molecular targets of PBM in mitigating GCI-induced brain damage.

Main Methods:

• Administered PBM therapy using an 808-nm diode laser 6 hours post-GCI in a rodent model.
• Assessed neuronal survival in the hippocampal CA1 subregion and evaluated spatial learning and memory functions.
• Conducted mechanistic studies on mitochondrial dynamics, oxidative stress, mitophagy, apoptosis, and in vitro validation using cytochrome c oxidase.

Main Results:

• PBM dose-dependently protected against GCI-induced neuronal death in the CA1 region.
• PBM significantly preserved short-term and long-term spatial learning and memory functions.
• Mechanistically, PBM preserved mitochondrial dynamics, reduced oxidative damage and mitophagy, inhibited apoptosis, and targeted cytochrome c oxidase.

Conclusions:

• PBM therapy is a promising strategy for functional recovery after GCI.
• PBM's neuroprotective effects are mediated by preserving mitochondrial function and dynamics.
• PBM inhibits delayed apoptotic neuronal death, offering a potential alternative to hypothermia.